Pfizer Inc (PFE)
Operating return on assets (Operating ROA)
| Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | ||
|---|---|---|---|---|---|---|
| Operating income | US$ in thousands | 14,938,000 | 3,359,000 | 40,030,000 | 24,833,000 | 10,630,000 |
| Total assets | US$ in thousands | 213,396,000 | 226,501,000 | 197,206,000 | 181,477,000 | 154,229,000 |
| Operating ROA | 7.00% | 1.48% | 20.30% | 13.68% | 6.89% |
December 31, 2024 calculation
Operating ROA = Operating income ÷ Total assets
= $14,938,000K ÷ $213,396,000K
= 7.00%
The operating return on assets (ROA) for Pfizer Inc has shown fluctuations over the years. In 2020, the operating ROA was 6.89%, which increased significantly to 13.68% in 2021 and further rose to 20.30% in 2022, indicating improved operational efficiency and profitability. However, there was a notable decline in 2023, with the operating ROA dropping to 1.48%, which may suggest challenges or one-time factors impacting performance. In 2024, the operating ROA recovered to 7.00%, which could indicate a partial rebound in profitability. Overall, Pfizer's operating ROA trend reflects varying levels of efficiency in generating operating profits from its assets, which may warrant further investigation to understand the underlying factors driving these fluctuations.
Peer comparison
Dec 31, 2024